查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702114

感染监测解决方案市场报告，按组件（软体、服务）、部署类型（本地、基于云端）、最终用户（医院、诊所、门诊服务中心、专科中心等）和地区划分，2025 年至 2033 年

Infection Surveillance Solutions Market Report by Component (Software, Services), Deployment Type (On-premises, Cloud-based), End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球感染监测解决方案市场规模达 7.025 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 13.639 亿美元，2025-2033 年期间的成长率 (CAGR) 为 7.27%。不断增长的医疗相关感染 (HAI)、防止感染传播的严格监管合规性以及允许自动捕获患者资料的医疗 IT 的进步是推动市场发展的一些主要因素。

感染监测解决方案是医疗机构采用的综合系统，用于监测和分析患者群体中感染的流行程度、传播和影响。他们利用先进的资料收集、整合和分析工具来追踪和报告各种医疗相关感染（HAI），例如血液感染、手术部位感染和呼吸道感染。由于它们使医疗保健提供者能够及时发现潜在的疫情爆发、实施有针对性的干预措施并最终提高患者安全，因此全球对感染监测解决方案的需求正在增加。

目前，人们对包括感染控制在内的患者安全的日益关注正在促进市场的成长。与此相符的是，人们越来越意识到数据驱动决策在医疗保健领域的重要性，这促进了市场的成长。此外，老年族群更容易受到感染，因此对感染监测解决方案的需求不断增长，这对市场产生了积极影响。此外，用于监测和减轻传染病爆发的监控解决方案的投资不断增加，为行业投资者提供了丰厚的成长机会。此外，资料分析、人工智慧 (AI) 和机器学习 (ML) 方面的创新正在增强感染监测解决方案的能力并使其更加高效，从而支持市场的成长。除此之外，全球医疗保健基础设施的改善也促进了市场的成长。

感染监测解决方案市场趋势/驱动因素：

医院相关感染（HAI）不断增加

由于个人医疗保健相关感染 (HAI) 的不断增加，感染监测解决方案的采用率不断提高，从而促进了市场的成长。同时，这些感染对患者的健康造成威胁，导致住院时间延长、医疗费用增加，甚至在某些情况下导致死亡。除此之外，减轻这些感染以提高病人安全性的需求也在增加。透过持续监测和分析患者资料，这些解决方案能够及早发现感染并允许医疗机构及时实施干预。因此，减少医院感染不仅可以改善病患的治疗效果，还可以为医疗机构节省成本。

严格遵守法规，防止感染蔓延

在医疗保健行业，遵守监管要求和认证标准至关重要。医疗保险和医疗补助服务中心 (CMS) 和联合委员会等监管机构正在强制报告和预防医疗相关感染 (HAI)。此外，不遵守规定可能会导致处罚和声誉损害。除此之外，感染监测解决方案对于确保合规性至关重要。它们有助于准确收集、分析和报告感染率资料，帮助医疗机构有效地满足监管要求。此外，认证机构将感染控制视为医疗保健品质的关键组成部分。此外，医疗保健组织正在投资先进的感染监测系统，这不仅满足监管需求，而且有助于获得和维持认证，提高其声誉和可信度。

医疗保健IT的进步

电子健康记录 (EHR)、健康资讯交换 (HIE) 和综合健康系统的日益普及正在推动市场的成长。与此相符的是，感染监测解决方案可以与现有的医疗保健 IT 基础设施无缝连接，并允许自动捕获患者资料、实验室结果和其他相关资讯。这些系统的介面简化了监控流程并确保了即时资料的可用性以进行分析，这为市场前景带来了积极的影响。医疗保健专业人员可以快速获得可操作的见解，有助于及早发现和应对潜在的疫情。此外，这些解决方案和医疗保健 IT 不仅增强了感染控制，而且还提高了医疗保健的整体效率和有效性。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球感染监测解决方案市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：按组成部分

  • 软体
  • 服务

第七章：市场区隔：依部署类型

  • 本地
  • 基于云端

第八章：市场区隔：按最终用户

  • 医院
  • 诊所
  • 门诊服务中心
  • 专业中心
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Centrak Inc. (Halma plc)
    • Cerner Corporation
    • CKM Healthcare Incorporated
    • Ecolab Inc.
    • International Business Machines Corporation
    • Medexter Healthcare
    • Perahealth Inc.
    • PointClickCare
    • Premier Inc.
    • Sunquest Information Systems Inc. (Roper Technologies Inc.)
Product Code: SR112025A4857

The global infection surveillance solutions market size reached USD 702.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,363.9 Million by 2033, exhibiting a growth rate (CAGR) of 7.27% during 2025-2033. The growing healthcare-associated infections (HAIs), stringent regulatory compliance for preventing the spread of infection, and advancements in healthcare IT that allow for the automatic capture of patient data are some of the major factors propelling the market.

Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.

At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.

Infection Surveillance Solutions Market Trends/Drivers:

Rising healthcare-associated infections (HAIs)

The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.

Stringent regulatory compliance for preventing spread of infection

In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.

Advancements in healthcare IT

The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.

Infection Surveillance Solutions Industry Segmentation:

Breakup by Component:

  • Software
  • Services

Software represents the largest market segment

Breakup by Deployment Type:

  • On-premises
  • Cloud-based

On-premises accounts for the majority of the market share

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Service Centers
  • Specialty Centers
  • Others

Hospitals hold the biggest market share

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.

Competitive Landscape:

Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Baxter International Inc.
  • Becton Dickinson and Company
  • Centrak Inc. (Halma plc)
  • Cerner Corporation
  • CKM Healthcare Incorporated
  • Ecolab Inc.
  • International Business Machines Corporation
  • Medexter Healthcare
  • Perahealth Inc.
  • PointClickCare
  • Premier Inc.
  • Sunquest Information Systems Inc. (Roper Technologies Inc.)

Key Questions Answered in This Report

  • 1.What was the size of the global infection surveillance solutions market in 2024?
  • 2.What is the expected growth rate of the global infection surveillance solutions market during 2025-2033?
  • 3.What are the key factors driving the global infection surveillance solutions market?
  • 4.What has been the impact of COVID-19 on the global infection surveillance solutions market?
  • 5.What is the breakup of the global infection surveillance solutions market based on the component?
  • 6.What is the breakup of the global infection surveillance solutions market based on the deployment type?
  • 7.What is the breakup of the global infection surveillance solutions market based on the end user?
  • 8.What are the key regions in the global infection surveillance solutions market?
  • 9.Who are the key players/companies in the global infection surveillance solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Surveillance Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Deployment Type

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Service Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Specialty Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Centrak Inc. (Halma plc)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cerner Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 CKM Healthcare Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ecolab Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 International Business Machines Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medexter Healthcare
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perahealth Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 PointClickCare
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Premier Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sunquest Information Systems Inc. (Roper Technologies Inc.)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2024
  • Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2024
  • Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
  • Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
  • Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million USD), 2025-2033
  • Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
  • Table 7: Global: Infection Surveillance Solutions Market: Key Players